Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes
Sponsor: Tel-Aviv Sourasky Medical Center
Summary
This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.
Official title: Early Cardiovascular Risk Assessment of Patients With COPD During Respiratory Exacerbation for the Identification and Treatment of Cardiovascular Comorbidity
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2025-03-01
Completion Date
2027-08-01
Last Updated
2025-09-30
Healthy Volunteers
No
Interventions
Cardiologist evaluation
The cardiology consultation will include the following: a structured interview (see Appendix A), physical examination, review of laboratory tests including HbA1c, lipid profile, BNP, ECG, and POCUS (point-of-care ultrasound) to assess heart contraction and valve function.
Pulmonologist evaluation
optimize basic treatment, and recommend continued follow-up as needed.
Locations (1)
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel